2015
DOI: 10.17116/terarkh20158710110-114
|View full text |Cite
|
Sign up to set email alerts
|

Asthma and metabolic syndrome: Clinical and pathogenetic relationships

Abstract: Asthma and metabolic syndrome (MS) are common and social diseases. External and internal factors influencing the development and manifestations of asthma are identified; among which there is obesity that is a major risk factor for MS. Accordingly, the concurrence of asthma and MS and to study their clinical and pathogenetic relationships are a topical problem. There is a tendency to identify a particular asthma phenotype that is characterized by later-onset disease in the presence of obesity; the low prevalenc… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0
1

Year Published

2019
2019
2023
2023

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 7 publications
(4 citation statements)
references
References 31 publications
0
3
0
1
Order By: Relevance
“…Patients with comorbid COPD and CHF are in a state of prolonged hypoxia: permanent (chronic respiratory failure) or intermittent [9,10,11]. Intermittent hypoxia can occur during exercise, exacerbation of COPD or CHF decompensation and during sleep.…”
Section: Discussionmentioning
confidence: 99%
“…Patients with comorbid COPD and CHF are in a state of prolonged hypoxia: permanent (chronic respiratory failure) or intermittent [9,10,11]. Intermittent hypoxia can occur during exercise, exacerbation of COPD or CHF decompensation and during sleep.…”
Section: Discussionmentioning
confidence: 99%
“…Bronchial asthma (BA) is a heterogeneous disease characterized by chronic inflammation of the airways, the presence of respiratory symptoms such as wheezing, shortness of breath and cough that vary in time and intensity [1][2][3]. According to World Health Organization in 2016 up to 339 million people of all ages worldwide suffered from the disease.…”
Section: Introductionmentioning
confidence: 99%
“…It is the heterogeneity of the disease that dictates the need for the most individualized treatment. (1,2) The heterogeneity of both clinical manifestations of asthma and response to therapy is considered nowadays. (3,4) We distinguish many asthma phenotypes, and even subphenotypes, based on those factors.…”
Section: Introductionmentioning
confidence: 99%